Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates — Positive

IPSC   Zacks Investment Research — May 15, 2025

Century Therapeutics, Inc. (IPSC) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of a loss of $0.31 per share. This compares to loss of $0.45 per share a year ago.

image for news Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates

Verisk Analytics: Benefiting From A Premium Increase But Overvalued — Positive

VRSK   Seeking Alpha — May 15, 2025

Verisk Analytics has delivered a strong quarterly result in both underwriting and claims segments. The management highlighted the tailwind from premium increases due to elevated levels of business risks. Verisk Analytics has been launching new databases to expand its business scopes.

image for news Verisk Analytics: Benefiting From A Premium Increase But Overvalued

NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of EchoStar Corporation ("EchoStar Corporation") (NASDAQ:SATS) concerning possible violations of federal securities laws. The Wall Street Journal reported on May 12, 2025, that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network.

image for news Lost Money on EchoStar Corporation (SATS)? Contact Levi & Korsinsky to Protect Your Rights

Gold Consolidates; Likely Supported by Signs of Disinflation — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   WSJ — May 15, 2025

Gold consolidated in the early Asian trade, but is likely supported by signs of disinflation.

image for news Gold Consolidates; Likely Supported by Signs of Disinflation

Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript — Neutral

TIVC   Seeking Alpha — May 15, 2025

Tivic Health Systems Inc. (NASDAQ:TIVC ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jennifer Ernst – Chief Executive Officer Lisa Wolf – Interim Chief Financial Officer Michael Handley – Chief Operating Officer and President-Tivic Biopharma Division Conference Call Participants Operator Welcome to Tivic Health Systems First Quarter 2025 Financial Results and Operational Update Conference Call. This call has been prerecorded, and the questions you have submitted in advance will be answered following the prepared remarks.

image for news Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript

Main Street Capital remains a top-quality BDC with solid fundamentals, strong management, and consistent income generation, as evidenced by robust Q1 earnings. Despite a recent 11.5% price decline, MAIN still trades at a 68.5% premium to NAV, well above its historical average. Macro risks and sector-wide premium valuations make me hesitant to add to my MAIN position or increase BDC exposure right now.

image for news Main Street Capital: A Good Choice To Navigate Concerns Of The BDC Sector

RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call Transcript — Neutral

RNXT   Seeking Alpha — May 15, 2025

RenovoRx, Inc. (NASDAQ:RNXT ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Valter Pinto - IR Ramtin Agah - Founder and Chief Medical Officer Shaun Bagai - CEO Ronald Kocak - VP Controller and Principal Accounting Officer Conference Call Participants Rafay Khalid - Ascendiant Capital Markets Operator Good afternoon, everyone, and welcome to the RenovoRx Q1 2025 Financial and Operational Highlights Conference Call. All participants will be in a listen-only mode.

image for news RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call Transcript

Warner Bros. Discovery, Inc. (NASDAQ:WBD ) MofafettNathanson 2025 Media, Internet & Communications Conference May 15, 2024 3:10 PM ET Company Participants Gunnar Wiedenfels - Chief Financial Officer Conference Call Participants Robert Fishman - MoffettNathanson Robert Fishman So thank you.

image for news Warner Bros. Discovery, Inc. (WBD) MofafettNathanson 2025 Media, Internet & Communications Conference (Transcript)

Origin Materials, Inc. (ORGN) Q1 2025 Earnings Call Transcript — Neutral

ORGN   Seeking Alpha — May 15, 2025

Origin Materials, Inc. (NASDAQ:ORGN ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Ryan Smith - Co-Founder & Chief Product Officer Rich Riley - Co-Chief Executive Officer John Bissell - Co-Founder & Co- Chief Executive Officer Matt Plavan - CFO & COO Conference Call Participants Operator Good day and welcome to the Origin Materials First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode [Operator Instructions] Please note that this event is being recorded.

image for news Origin Materials, Inc. (ORGN) Q1 2025 Earnings Call Transcript

KORE Group Holdings, Inc. (KORE) Q1 2025 Earnings Call Transcript — Neutral

KORE   Seeking Alpha — May 15, 2025

KORE Group Holdings, Inc. (NYSE:KORE ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Vik Vijayvergiya - Vice President of Investor Relations and Corporate Development Ron Totton - President and Chief Executive Officer Paul Holtz - Chief Financial Officer Conference Call Participants Scott Searle - ROTH Capital Partners Lance Vitanza - TD Cowen Operator Greetings, and welcome to KORE Group Holdings, Incorporated First Quarter 2025 Earnings Call. [Operator Instructions] Please note that this conference is being recorded.

image for news KORE Group Holdings, Inc. (KORE) Q1 2025 Earnings Call Transcript

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) on behalf of long-term stockholders following a class action complaint that was filed against Kyverna on December 9, 2024 with a Class Period pursuant and/or traceable to the Company's offering documents issued in connection with its initial public offering (“IPO”) conducted on February 8, 2024. Our investigation concerns whether the board of directors of Kyverna have breached their fiduciary duties to the company.

image for news KYVERNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Kyverna Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ:SATS) on behalf of EchoStar stockholders. Our investigation concerns whether EchoStar has violated the federal securities laws and/or engaged in other unlawful business practices.

image for news ECHOSTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating EchoStar Corporation on Behalf of EchoStar Stockholders and Encourages Investors to Contact the Firm

SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that it granted stock options to purchase an aggregate of 461,000 shares of Tenaya common stock to three new non-executive employees in connection with the commencement of their employment. The stock options have an exercise price of $0.4373 per share, which is equal to the closing price of Tenaya's common stock on May 15, 2025. Each stock option has a …

image for news Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Fake puppies and phony offers of mouthwatering bargains are often seeded by overseas crime networks; employees says company is reluctant to impede its advertising juggernaut

image for news Meta Battles an ‘Epidemic of Scams' as Criminals Flood Instagram and Facebook

The company's announcement on tariffs sends a clear signal that higher prices are on the way.

image for news Walmart's Price Hikes Open Door to Increases From ‘Everybody Else'

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf of long-term stockholders following a class action complaint that was filed against Geron on March 14, 2025 with a Class Period from February 28, 2024 to February 25, 2025. Our investigation concerns whether the board of directors of Geron have breached their fiduciary duties to the company.

image for news GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against ModivCare, Inc. (NASDAQ: MODV) on behalf of long-term stockholders following a class action complaint that was filed against ModivCare on January 29, 2025 with a Class Period from November 3, 2022, to September 15, 2024. Our investigation concerns whether the board of directors of ModivCare have breached their fiduciary duties to the company.

image for news MODIVCARE ALERT: Bragar Eagel & Squire, P.C. is Investigating ModivCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSE: DOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.

image for news DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE:ELV) in the United States District Court for the Southern District of Indiana on behalf of all persons and entities who purchased or otherwise acquired Elevance securities between April 18, 2024, and October 16, 2024, both dates inclusive (the “Class Period”). Investors have until July 11, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

image for news ELEVANCE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Encourages Investors to Contact the Firm

KULR Technology Group, Inc. (KULR) Q1 2025 Earnings Call Transcript — Neutral

KULR   Seeking Alpha — May 15, 2025

KULR Technology Group, Inc. (NYSE:KULR ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Stuart Smith - Investor Relations Michael Mo - Chief Executive Officer Shawn Canter - Chief Financial Officer Conference Call Participants Stuart Smith Welcome everyone to the KULR Technology Group First Quarter 2025 Earnings Call. I'm your moderator for the call, Stuart Smith.

image for news KULR Technology Group, Inc. (KULR) Q1 2025 Earnings Call Transcript